Is a 2-week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?

J Med Virol. 2024 May;96(5):e29617. doi: 10.1002/jmv.29617.

Authors

Joo-Hee Hwang^{1

2}, Jeong-Hwan Hwang^{1

2}

Affiliations

¹ Department of Internal Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, Republic of Korea.
² Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.

PMID: 38742694
DOI: 10.1002/jmv.29617

No abstract available

Publication types

Letter

MeSH terms

Adult
Antiviral Agents / administration & dosage
Antiviral Agents / therapeutic use
CD4 Lymphocyte Count
Female
HIV Infections* / drug therapy
HIV Infections* / immunology
Humans
Male
Middle Aged
Treatment Outcome